| # | Drug | Count |
|---|---|---|
| 0 | QUETIAPINE | 18 |
| 1 | ADALIMUMAB | 12 |
| 2 | INTERFERON BETA-1A | 10 |
| 3 | NATALIZUMAB | 10 |
| 4 | ACETAMINOPHEN | 8 |
| 5 | FOLIC ACID | 7 |
| 6 | IRON | 7 |
| 7 | QUETIAPINE FUMARATE | 7 |
| 8 | VENLAFAXINE | 7 |
| 9 | VENLAFAXINE HYDROCHLORIDE | 7 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 12 |
| 1 | Corticosteroid [EPC] | 12 |
| 2 | Interferon beta [EPC] | 11 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 11 |
| 4 | Vitamin B12 [EPC] | 11 |
| 5 | Vitamin C [EPC] | 11 |
| 6 | Integrin Receptor Antagonist [EPC] | 10 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 9 |
| 8 | Vitamin D [EPC] | 9 |
| 9 | Cytochrome P450 3A Inhibitor [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Oxytocic [EPC] | 4 | 0.0013 |
| 1 | Prostaglandin E1 Analog [EPC] | 6 | 0.0004 |
| 2 | Cholinergic Muscarinic Agonist [EPC] | 1 | 0.0004 |
| 3 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 1 | 0.0002 |
| 4 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 5 | Provitamin D2 Compound [EPC] | 5 | 0.0002 |
| 6 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0002 |
| 7 | Protease Inhibitor [EPC] | 7 | 0.0002 |
| 8 | Human Immunoglobulin G [EPC] | 3 | 0.0001 |
| 9 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |